跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
HSA
/
RELESTAL PEDIATRIC SYRUP 10 mg/5 ml
Approved
THERAPEUTIC
RELESTAL PEDIATRIC SYRUP 10 mg/5 ml
UNITED LABORATORIES INC
🇸🇬 Health Sciences Authority
Approval Date
Apr 25, 2003
Approval ID
98cf71cc644db452
Company
UNITED LABORATORIES INC
Type
Therapeutic
Approval Details
Approval Id
98cf71cc644db452
Drug Name
RELESTAL PEDIATRIC SYRUP 10 mg/5 ml
Product Name
RELESTAL PEDIATRIC SYRUP 10 mg/5 ml
Approval Number
SIN12259P
Approval Date
2003-04-25
Registrant
FAR EAST DRUG COMPANY (PRIVATE) LIMITED
Licence Holder
FAR EAST DRUG COMPANY (PRIVATE) LIMITED
Drug Type
Therapeutic
Forensic Classification
Pharmacy Only
Dosage Form
SYRUP
Route Of Administration
ORAL
Atc Code
A03AA07
Atc Item Name
dicycloverine
Pharma Manufacturer Name
FAR EAST DRUG COMPANY (PRIVATE) LIMITED
Company Detail Path
/organization/far-east-drug-company-private-limited
Active Ingredients
DICYCLOVERINE HCl
10 mg/5 ml
DICYCLOVERINE HCL
10 MG/5 ML
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Apr 25, 2003
Approval ID
98cf71cc644db452
Type
Therapeutic
Back to HSA Approvals
RELESTAL PEDIATRIC SYRUP 10 mg/5 ml - HSA Drug Approval Details